CLSA Events

Novo Nordisk Partnering Day

Partnering for innovation in protein-based therapeutics 

Novo Nordisk A/S is a focused healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within hemostasis management and growth hormone therapy.

The focus of ‘Novo Nordisk Partnering Day’ will be on Diabetes and Obesity therapeutics. Our aim is to identify innovative and novel biologics at all stages of development – from early discovery to clinical phases- with the objective to create licensing and partnering strategies.

Novo Nordisk is based in Denmark with nearly 40,000 employees world-wide, and markets its products in 179 countries. Our main research site is in Copenhagen, Denmark. Novo Nordisk’s research Centre in Beijing is the first research Centre established in China by an international pharmaceutical company. In addition, our Novo Nordisk Research Center in Seattle, WA, USA houses US-based research units in Type 1 diabetes, Obesity and a small protein  and peptide production team.

Areas of Interest

  • Type 2 Diabetes
  • Obesity
  • Protein /peptide technologies (e.g. half-life extensions, oral, and stabilizing)

Novo Nordisk way of partnering

Our history tells us that creativity thrives in partnerships. We are dedicated to patient care and to our business, and we are open to a wide range of partnering models from in-licensing to sophisticated partnerships. Novo Nordisk works with a carefully defined process from opportunity identification to deal making to ensure optimal communication with our potential partners.

Novo Nordisk way of doing business

The Triple Bottom Line is the principle that guides Novo Nordisk’s way of doing business. It primes our business for long-term growth and drives our commitment to sustainable development: To meet the needs of the present without compromising the ability of future generations to meet their needs. In day-to-day business, this implies that all decisions must seek to balance three considerations: Is it economically viable? Is it socially responsible? Is it environmentally sound? This is the Triple Bottom Line, which ensures that decision-making balances financial growth with corporate responsibility, short-term gains with long-term growth, and shareholder return with other stakeholders.

Novo Nordisk Participants:

S‪ø‬ren Bregenholt, Corporate Vice President, External Innovation & Stakeholder Relations

Barbara  Araneo, Director, R&D Innovation Sourcing

Anand Gautam, Director, R&D Innovation Sourcing

Miriam Frieden, VP of R&D Innovation Sourcing


Novo Nordisk Partnering Day


November 9, 2015

8:30 am — 9:15 am Plenary Address: Novo Nordisk Partner of Choice

Join us for a morning plenary address with the Novo Nordisk Team and learn how a large biopharmaceutical company evaluates external research and approaches licensing and partnerships, followed by a Q&A panel discussion

9:30 am — 4:00 pm One-on-one meetings

5:30 pm — 7:00 pm Networking Cocktail Reception

This event will provide a great opportunity to network with Novo Nordisk senior R&D and business development Leadership.


San Mateo Marriott San Francisco Airport
1770 S Amphlett Blvd.
San Mateo, CA 94402



Valet and Self-Parking Available Onsite (fee applies)


One-on-One Meeting: Application is required for one-on-one meetings. Only companies reviewed and approved will be scheduled for a one-on-one partnering meeting. Application review is on a rolling basis, so we suggest applying early due to a limited number of available appointments.

Networking Cocktail Reception: Due to high demand the reception is limited to employees of bioscience companies only. For questions please email

Plenary & Panel Discussion: Due to high demand the morning plenary is limited to employees of bioscience companies only. For questions please email

Attire:Business attire suggested
  • Early registration is highly advised as space is limited and there will be no on-site registration
  • Pre-registered attendees will receive an immediate receipt/confirmation after submission
  • Please print this receipt/confirmation and bring it with you to receive your conference credentials
  • Photo ID (driver’s license or passport) will be required at check-in
  • All sales are final

Please mail your event-related questions to: or you can contact us via phone: 650-871-3257.

Is your company a member? Click here to check.